Wide-reaching report finds strong support for nurse and pharmacist prescribing

Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report

 

Southampton (May 10, 2011) – Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report.

 

Health service researchers from the universities of Southampton and Keele found widespread acceptance of the new powers among patients and that prescribing practices were safe and appropriate for the type of medical conditions being treated.

 

The Department of Health-funded report, published today (Tuesday, 10 May 2011), gives a national ’snapshot‘ of how successfully nurse and pharmacist prescribing is being used in primary care trusts, GP surgeries and hospitals.

 

"This study is the first national evaluation of independent prescribing by nurses and pharmacists since legislation in 2006 enabled nurses and pharmacists to independently prescribe across an extensive range of medicines. Our research shows that the practice is becoming a well–integrated and established means of managing a patient’s condition," comments Sue Latter, professor of nursing at the University of Southampton, who led the study.

 

"We were also able to highlight areas to the government where expansion of non-medical prescribing could strengthen NHS services in order to meet health care needs of the future."

 

The legislation, which gave experienced nurses and pharmacists powers to prescribe medication to patients, was viewed by some as controversial when it was introduced in 2006. Specially trained nurses and pharmacists in England are now able to manage all aspects of a patient’s treatment including diagnosis, prescription and monitoring, without supervision by a doctor.

 

"Our research shows that nurse and pharmacist independent prescribers are now making a substantial contribution to patient care which is safe and of good quality," says Alison Blenkinsopp, professor of the practice of pharmacy at Keele University.

 

"Commissioners of healthcare can use our findings to make the most effective use of nurse and pharmacist prescribing when they are commissioning services."

 

The report also found that:

 

  • 86 per cent of nurses and 71 per cent of pharmacists are using their new powers after training as a prescriber.
  • Most nurses and pharmacists are prescribing in a primary care setting, with substantial numbers also in secondary care settings, such as hospitals.
  • Most patients did not mind whether they received care from a nurse, pharmacist or a doctor.
  • Enabling non-medical prescribing to develop further, by additional training of nurses and pharmacists to treat patients with more than one medical condition, could improve patient care and efficiency in the health service.

 


 

University of Southampton, Sophie Docker; Nursing News 10.05.2011 (tB).

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…